These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 5492591)

  • 1. 5-fluorocytosine: a replacement for amphotericin B in the treatment of candida and cryptococcus neoformans infections?
    Pankey GA; Lockwood WR; Montalvo JM
    J La State Med Soc; 1970 Dec; 122(12):365-9. PubMed ID: 5492591
    [No Abstract]   [Full Text] [Related]  

  • 2. 5-fluorocytosine in the treatment of cryptococcal and candida mycoses.
    Fass RJ; Perkins RL
    Ann Intern Med; 1971 Apr; 74(4):535-9. PubMed ID: 5551162
    [No Abstract]   [Full Text] [Related]  

  • 3. [Letter: Meningoencephalic cryptococcosis. Presence of filamentous forms. Acquired resistance to 5 fluorocytosine and amphotericin B therapy].
    Cadoz M; Micoud M; Pasquier B; Massot C; Goullier A
    Nouv Presse Med; 1974 Oct; 3(33):2108-9. PubMed ID: 4444954
    [No Abstract]   [Full Text] [Related]  

  • 4. In vitro susceptibility of Cryptococcus neoformans to amphotericin B, hamycin, and 5-fluorocytosine.
    Shadomy S; Shadomy HJ; McCay JA; Utz JP
    Antimicrob Agents Chemother (Bethesda); 1968; 8():452-60. PubMed ID: 5735392
    [No Abstract]   [Full Text] [Related]  

  • 5. Cryptococcal meningitis treated with 5-fluorocytosine and amphotericin B.
    Halkin H; Ravid M; Zulman J; Reichert N
    Isr J Med Sci; 1974 Sep; 10(9):1148-52. PubMed ID: 4611967
    [No Abstract]   [Full Text] [Related]  

  • 6. [On meningoencephalitis caused by Cryptococcus neoformans. Diagnostic and therapeutic study].
    Arcuri F; Robert L; Cavallero F
    Arch Maragliano Patol Clin; 1971; 27(2):99-121. PubMed ID: 4401355
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antimycotic activity in vitro and in vivo of 5-fluorocytosine on pathogenic strains of Candida albicans and Cryptococcus neoformans].
    Costa AL; Valenti A; Costa G; Calogero F
    G Batteriol Virol Immunol; 1976; 69(7-12):244-9. PubMed ID: 800772
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of cryptococcal meningoencephalitis; value of 5-fluorocytosine].
    Dufresne JJ
    Rev Med Suisse Romande; 1972 Aug; 92(8):597-614. PubMed ID: 4656396
    [No Abstract]   [Full Text] [Related]  

  • 9. 5-fluorocytosine in human candidiasis.
    Warner JF; McGehee RF; Duma RJ; Shadomy S; Utz JP
    Antimicrob Agents Chemother (Bethesda); 1970; 10():473-5. PubMed ID: 5521370
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-fluorocytosine in the treatment of mycotic infections.
    Vandevelde AG; Mauceri AA; Johnson JE
    Ann Intern Med; 1972 Jul; 77(1):43-51. PubMed ID: 4559539
    [No Abstract]   [Full Text] [Related]  

  • 11. [Oral antimycotic agent, 5-fluorocytosine].
    Scholer HJ
    Mykosen; 1970 Apr; 13(4):179-88. PubMed ID: 4986625
    [No Abstract]   [Full Text] [Related]  

  • 12. The antimycotic activity of 5-fluorocytosine.
    Holt RJ; Newman RL
    J Clin Pathol; 1973 Mar; 26(3):167-74. PubMed ID: 4700499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-fluorocytosine: an oral antifungal compound. A report on clinical and laboratory experience.
    Steer PL; Marks MI; Klite PD; Eickhoff TC
    Ann Intern Med; 1972 Jan; 76(1):15-22. PubMed ID: 5063168
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug therapy of cryptococcosis and chromomycosis using 5-fluorocytosine].
    González Ochoa A
    Rev Invest Salud Publica; 1970; 30(1):63-76. PubMed ID: 5433834
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro sensitivity to amphotericin B of Cryptococcus neoformans isolated in Thailand.
    Gaew-Im M; Thasnakorn P
    J Med Assoc Thai; 1971 Jan; 54(6):405-9. PubMed ID: 5171413
    [No Abstract]   [Full Text] [Related]  

  • 16. [Cryptococcus neoformans meningoencephalitis].
    Langberg CW; Barkve H; Tjørstad K
    Tidsskr Nor Laegeforen; 1984 May; 104(14):968-70. PubMed ID: 6087494
    [No Abstract]   [Full Text] [Related]  

  • 17. Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms.
    Medoff G; Comfort M; Kobayashi GS
    Proc Soc Exp Biol Med; 1971 Nov; 138(2):571-4. PubMed ID: 5118468
    [No Abstract]   [Full Text] [Related]  

  • 18. Cryptococcal meningoencephalitis and 5-fluorocytosine.
    Beine JP; Lontie M; Vandepitte J
    Br Med J; 1971 Apr; 2(5753):107. PubMed ID: 4927910
    [No Abstract]   [Full Text] [Related]  

  • 19. Antifungal susceptibilities of clinical isolates of Candida species, Cryptococcus neoformans, and Aspergillus species from Taiwan: surveillance of multicenter antimicrobial resistance in Taiwan program data from 2003.
    Hsueh PR; Lau YJ; Chuang YC; Wan JH; Huang WK; Shyr JM; Yan JJ; Yu KW; Wu JJ; Ko WC; Yang YC; Liu YC; Teng LJ; Liu CY; Luh KT
    Antimicrob Agents Chemother; 2005 Feb; 49(2):512-7. PubMed ID: 15673726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival of a patient transplanted with a kidney infected with Cryptococcus neoformans.
    Ooi BS; Chen BT; Lim CH; Khoo OT; Chan DT
    Transplantation; 1971 Apr; 11(4):428-9. PubMed ID: 4934356
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.